Cecelia Koetting, OD, FAAO, DipABO

Results of the BRIO-I study, the first of 2 phase 3 clinical trials of Brimochol PF, a topical, fixed-dose combination for the treatment of presbyopia, have recently been released.

Cecelia Koetting, OD, FAAO, shares insights from her AOA 2023 presentation on Demodex diaries.

Provide better, more cohesive patient care with comanagement.

The ones you should seek out—and avoid.

Intact corneal tissue can be reused for preservation and reimplantation.

FDA-approved steroid offers short-term relief for ocular surface inflammation.

Evaluating patients’ eyelids before cataract and refractive surgery is crucial, as ptosis can create unwanted adverse effects and alter outcomes.

Dr. Koetting asks: When do you feel it is time to discuss cataracts with your patients?

During AOA 2022, Cecelia Koetting, OD, FAAO, shares highlights from her presentation titled "Ocular Surgeries and the Role of the Paraoptometric."

Posterior chamber pIOLs should be considered for patients in which other refractive surgeries may not be an option and as an reversible alternative with fewer complications.

What to ask when triaging a patient

What to ask when triaging a patient